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ABSTRACT
Objective: To explore patients’ experiences from initial
symptoms to receiving a diagnosis of gout.
Design: Data from in-depth semistructured interviews
were used to construct themes to describe key features
of patients’ experiences of gout diagnosis.
Participants and setting: A maximum variation
sample of 43 UK patients with gout (29 men; 14
women; age range 32–87 years) were recruited from
general practices, rheumatology clinics, gout support
groups and through online advertising.
Results: Severe joint pain, combined with no obvious
signs of physical trauma or knowledge of injury,
caused confusion for patients attempting to interpret
their symptoms. Reasons for delayed consultation
included self-diagnosis and/or self-medication,
reluctance to seek medical attention, and financial/work
pressures. Factors potentially contributing to delayed
diagnosis after consultation included reported
misdiagnosis, attacks in joints other than the first
metatarsophalangeal joint, and female gender. The
limitations in using serum uric acid (SUA) levels for
diagnostic purposes were not always communicated
effectively to patients, and led to uncertainty and lack
of confidence in the accuracy of the diagnosis.
Resistance to the diagnosis occurred in response to
patients’ beliefs about the causes of gout and
characteristics of the people likely to be affected.
Diagnosis prompted actions, such as changes in diet,
and evidence was found of self-monitoring of SUA
levels.
Conclusions: This study is the first to report data
specifically about patients’ pathways to initial
consultation and subsequent experiences of gout
diagnosis. A more targeted approach to information
provision at diagnosis would improve patients’
experiences.
INTRODUCTION
Gout is the most common form of inflamma-
tory arthritis and affects around 2.5% of
adults in the UK.1 Clinical diagnosis is
straightforward when classical features such
as sudden onset of severe joint pain
(reaching peak intensity within 12–24 h),
swelling, tenderness and erythema affecting
the first metatarsophalangeal (MTP) joint
are present.2–8 When these features are not
present or joints other than the first MTP
joint are affected, definitive diagnosis
requires confirmation of the presence of
monosodium urate (MSU) crystals in synovial
fluid or tophi.6 However, the skills to
perform diagnostic joint aspiration are often
lacking in primary care,9 10 where the major-
ity of patients with gout are diagnosed and
managed.11 This can lead to various pro-
blems with diagnosis, including misdiagnosis,
Strengths and limitations of this study
▪ This study is the first to focus specifically on
patients’ experiences of gout diagnosis, includ-
ing their decisions about how and when to first
seek medical advice. A sample of people from
different social backgrounds and age groups
from across the UK were interviewed.
▪ Patients’ accounts and understandings of what
healthcare professionals did and said are, of
course, their own perceptions. Accounts of the
patient experience are of high importance in the
current patient-centred provision of healthcare.
▪ Data presented are based on patients’ retrospect-
ive accounts of their experiences, which may
change with time. In addition, some patients’
accounts of diagnosis and interactions with
healthcare professionals in the past years may
reflect issues or ideas that are no longer preva-
lent in current practice. However, the sample
also included patients diagnosed recently, imply-
ing that the study’s findings can be viewed as
applicable to routine practice.
▪ A maximum variation sample is not intended to
be numerically representative, but instead allows
in-depth exploration and insight into previously
hidden experiences of patients with gout, includ-
ing those who fit the ‘typical’ patient with gout
profile and those who do not. Consequently, the
use of relative frequencies is avoided in the text
to avoid confusion.
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delayed diagnosis, or underdiagnosis or overdiagno-
sis,11–18 particularly in females,19 among whom gout is
less common.1
Much evidence has already been published
documenting and measuring the extent of suboptimal
management of gout and the accuracy of diagno-
sis.1 3 13 14 18 20–24 Studies have focused on the quality
of gout management for diagnosed patients,14 18 21 25
but their emphasis has been primarily on treatment
and monitoring. Those articles that have considered
diagnosis have generally concentrated on diagnostic
methods or accuracy.22–24 However, this quantitative
research cannot capture patients’ stories or provide an
in-depth understanding of a patient’s experience and
perspectives. To date, there is limited gout research
using qualitative methodology. One qualitative study
focused on patients’ experiences in gout manage-
ment,26 but did offer some insight into patients’ experi-
ences of diagnosis. A reluctance to seek advice for
symptoms was reported. Negative connotations and per-
ceptions of gout as a man’s disease also meant that
some patients were initially unwilling to accept the diag-
nosis and/or to use the term ‘gout’ to refer to their
condition.26 Another qualitative study found that
patients had ‘vivid recollections’ of their first attacks of
gout.10
There has been no previously published research spe-
cifically examining patient experiences of gout diagnosis.
Researching diagnosis is important for understanding lay
experience of illness, patient compliance, health educa-
tion, and other aspects of health and illness, as well as for
improving non-biomedical aspects of clinical practice.27 28
This study aimed to explore patients’ pathways to consult-
ation and to describe key features of their experiences of
gout diagnosis.
RESEARCH METHODS
Design
This study aimed to explore patients’ pathways to gout
diagnosis and to capture their narratives of going
through this process. A qualitative design was used to
gain a greater understanding of patient experiences,
and to identify key features and issues within these
experiences.
Informed written consent was obtained from all
participants.
Sampling and recruitment
Maximum variation sampling (purposively selecting a
heterogeneous sample)29 was used to select the sample.
The rationale behind this method was that ‘common
patterns that emerge from great variation are of par-
ticular interest and value in capturing the core experi-
ences and central, shared aspects or impacts’ of gout
diagnosis.29 A wide range of recruitment methods was
employed, including the use of recruitment posters in
general practices and rheumatology clinics, information
packs handed out by members of the study advisory
group, information put on local and national gout
support group websites, and other online advertising
sites. Interview recordings were also intended for use as
an online resource about experiences of gout (health-
talk.org); thus, a wide geographical spread of partici-
pants was required to provide representation of people
across England, Wales and Scotland. A literature review,
and a clinical and user advisory group were used to
draw up a list of other categories (in addition to geo-
graphic region) that covered the types of experiences
and demographic variables that were considered to be
of most importance to clinicians and patients. Potential
participants who responded quickly to recruitment
advertisements were used to fill the most common cat-
egories (current age, age at diagnosis, sex and years
since gout diagnosis), with the only inclusion criteria
being a self-reported diagnosis of gout and a minimum
age >18 years. As the study progressed, recruitment was
targeted by selective recruitment of people who
responded to study advertisements (according to indi-
vidual characteristics) to ensure that all other categories
(nationality, geographical location, marital status, living
arrangements, work status, number of attacks in past
12 months) were covered. Ongoing recruitment was dis-
cussed by the research team and when 43 individuals
had been interviewed, it was agreed that a point of
data saturation had been reached and that the sample
was sufficient to provide representation across all
categories.
Data collection
Face-to-face individual semistructured interviews with 43
participants were conducted by an experienced qualita-
tive researcher ( JL). Participants were contacted by tele-
phone or email to fix the interviews. All interviews took
place in the participants’ homes or workplaces.
Following informed consent, interviews were audio or
video recorded depending on the participant’s prefer-
ence. A narrative approach30 was used to encourage
individuals to talk about living with gout and their
experiences. This facilitated the exploration of each
individual’s own concerns, meanings and priorities
related to gout diagnosis, rather than these being
imposed by predetermined questions.31 The researcher
used an interview guide to explore areas in more depth,
and to ask about topics that had not been previously
mentioned.
Data analysis
Interview recordings were transcribed verbatim and
checked by the researcher ( JL). NVivo V.9 (QSR) com-
puter software was used to facilitate data coding, sorting
and retrieval. JL read and re-read all transcripts and con-
structed a coding frame of themes using the method of
constant comparison.32 A second researcher (SP)
checked these to identify any additional codes. Analytic
themes relating to diagnosis were then discussed and
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developed further by JL and JCR,33 and existing models
of delays to diagnosis and pathways to treatment were
used as frameworks to assist in the analysis of the process
leading to diagnosis.34 35 Further analyses and extracts
from interviews are presented on http://www.healthtalk.
org and illustrated with interview excerpts.
RESULTS
Quotations are used to represent the range of responses
expressed by participants and illustrate the findings. All
names used are pseudonyms.
Sociodemographic characteristics
The sample included people from different age groups,
social backgrounds and geographical areas, people from
two ethnic groups, and men and women who had been
diagnosed recently as well as those who had lived with
gout for many years (table 1).
Overall findings
Experiences consistent with a typical onset of symptoms
featured strongly in patients’ accounts—they woke up
during the night or in the morning with severe pain36 37
which was often, though not exclusively, in the first
metatarsophalangeal (MTP) joint.2–5 Patients described
a distinctive pain, unlike any other they had experienced
before.
My left knee was in complete agony. I couldn’t bend it.
[…] it was not like any sort of pain I’d had before. It
wasn’t particularly swollen. […] there was no obvious
signs of injury. It was very debilitating because basically I
couldn’t move it at all. (Andrew, 50yrs)
Descriptions of gout causing the worst pain patients
had ever had—even compared with heart attacks and
childbirth—were common. This had made their first
attacks particularly memorable; therefore they were able
to give rich, detailed accounts of their gout pain
experiences.
A common belief among patients who described a
clinical diagnosis was that the diagnosis was made based
on blood tests to measure serum uric acid (SUA) levels,
despite the fact that these tests cannot confirm or
exclude a diagnosis of gout.5 6 Wendy described how
blood samples were taken, and the diagnosis was made
when she returned for the results of the SUA test:
So I got myself off to the doctors and that’s what he said,
‘oh yes it is red and it’s hot and, you know, I think you’ve
got gout’. But he said we won’t know for sure until we’ve
done these blood tests. (Wendy, 66yrs).
Main themes in diagnosis
The analysis resulted in six main themes related to diag-
nosis. Key points within each theme are summarised
below. Online supplementary material, including sup-
porting data and further details of each theme, is avail-
able at BMJ Open online.
Patients’ interpretations of symptoms
Patients described how, once they experienced pain
symptoms, they began to analyse these to try to identify
the cause and determine what action to take. Patients
considered a wide variety of possible causes for their
symptoms, including infection, insect bites, chilblains,
working too hard and broken toes. The intensity of pain
was sometimes particularly worrying because patients
thought it could be caused by a life-threatening illness.
The location of pain within and/or around a joint was a
factor that appeared to cause particular confusion. The
location, combined with the severity of the pain, led
patients to believe that the pain could be a result of
physical trauma, but this conflicted with their knowledge
that they had not injured themselves and could not see
any obvious signs of physical trauma.
Decisions about seeking medical attention
Patients’ approaches to deciding if or when to consult a
medical professional ranged widely, from those who
made an appointment to see the general practitioner
(GP) as soon as possible—often motivated by pain inten-
sity—to those who waited for several months or years
before seeking advice. Delays in seeking medical advice
were due to factors such as self-diagnosis/treatment,
financial pressures, and being on holiday abroad at the
time of a first attack.
I’d worked with it for 3 weeks, walking on the side of my
foot […] it’s probably the worst pain I’ve had, in my life
[…] I was a piece worker so what I made I got paid for, if
I didn’t make it, I didn’t get paid, so and, you know, we
were, young family then, so… […] eventually I just had
to give in and go to the Doctors and get signed off for a
week or two. (Steve, 64yrs)
Triggers and delays within the diagnostic interval
The ‘diagnostic interval’ describes the period of time
between the first appointment with a healthcare profes-
sional and the formal diagnosis being made.35 This
varied widely, from those who were diagnosed in their
first appointment or a few weeks later to those who were
not diagnosed until a later appointment, several months
or years later.
I went to the A&E […] I saw a doctor there and he
thought I’d been bitten on the foot, which was interest-
ing, and they gave me some drawing paste to put over
the actual area, it was the usual place, on the big toe,
swollen there, and he said, ‘If it doesn’t improve come
back and we’ll have a look at it’. […] Obviously it didn’t
improve […]The doctor didn’t identify what it was […]
it was just really a shot in the dark, so my medical advice
then was not geared towards gout. (Henry, 63yrs)
Patients talked about a number of delays and pro-
blems they encountered during the period before a
diagnosis was made, including misdiagnosis and diffi-
culty getting an appointment when symptoms were most
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severe. Some patients with gout attacks in joints other
than the first MTP joint, such as the knee, had their
symptoms attributed to other causes such as sports injur-
ies. Gender was another factor that appeared to cause
delays for some women.
Accepting or doubting the diagnosis
Patients who remained unconvinced about the accuracy
of the diagnosis either questioned the severity of their
symptoms, the method of diagnosis, or had not recon-
ciled the diagnosis with their ideas about the causes and
characteristics of people likely to be affected.
I often doubt, I think ‘oh have they got it wrong?’ you
know, because I don’t speak to anybody who’s got it,
especially my age, you’re talking like really—much older
men, like my Nanna knows people who’ve got it, but
[…] they’re not women. (Georgina, 41yrs)
Others felt that their diagnosis of gout was more the
result of a process of elimination than it was a process of
identification (or confirmation) of the condition,
leading them to suspect that doctors were ‘not sure’
about what was causing their symptoms.
Thoughts and feelings on receiving the diagnosis
A desire for greater information provision at the point
of diagnosis was a strong theme in the interviews. Not all
patients were aware that gout was a chronic condition
that required long-term management.
While some patients were not surprised by the diagno-
sis, others were shocked, angry or confused because they
believed their lifestyles were very different to those they
associated with gout. The contradiction was reinforced
by some health professionals placing an emphasis on
lifestyle changes. Resistance to the label of ‘gout’ fea-
tured strongly in some interviews, and some interviewees
chose to explain their symptoms as ‘arthritis’, rather
than as gout, to other people.
I think probably in the beginning, I didn’t actually tell
anyone. I just said, ‘Oh, I had a pain. I had trouble with
my big toe.’ […] I think because of that sort of possibly
kind of embarrassment. It’s easier to say that you’ve got
arthritis or something, rather than saying that you’ve got
gout. […] Probably because people might assume that
Table 1 Sociodemographic characteristics of sample
Men
(%)
(n=29)
Women
(%)
(n=14)
Total
(%)
(n=43)
Age group at interview (years)
30–49 4 (14) 3 (21) 7 (16)
50–69 16 (56) 7 (50) 23 (54)
70–89 9 (31) 4 (28) 13 (30)
Age group at diagnosis (years)
<30 1 (3) 1 (7) 2 (5)
30–49 19 (66) 4 (29) 23 (53)
50–69 9 (31) 7 (50) 16 (37)
70–89 – 2 (14) 2 (5)
Time since diagnosis (years)
1–5 4 (14) 6 (43) 10 (23)
6–10 2 (7) 4 (29) 6 (14)
11–15 6 (21) 3 (21) 9 (21)
≥16 17 (59) 1 (7) 18 (42)
Ethnicity/nationality
White British 27 (93) 13 (92) 40 (92)
Asian British 2 (7) 1 (7) 3 (7)
Geographical location
England 28 (97) 11 (79) 39 (91)
Scotland – 2 (14) 2 (5)
Wales 1 (3) 1 (7) 2 (5)
Living arrangements
Living alone 2 (7) 4 (29) 6 (14)
Living with one other
person
20 (69) 6 (43) 26 (60)
Living with more than one
other person
7 (24) 4 (29) 11 (26)
Marital status
Married/long-term partner 27 (93) 9 (64) 36 (84)
Single – 2 (14) 2 (5)
Divorced/separated – 2 (14) 2 (5)
Widowed 2 (7) 1 (7) 3 (7)
Current work status
Retired 16 (55) 9 (64) 25 (58)
Full-time work 6 (21) 5 (36) 11 (26)
Part time work 5 (17) – 5 (12)
Student (higher education) 1 (3) – 1 (2)
Not working for health
reasons
1 (3) – 1 (2)
Attacks in past 12 months
0 10 (3) 4 (29) 14 (33)
1–4 16 (55) 6 (43) 22 (51)
5–9 1 (3) 1 (7) 2 (5)
≥10 2 (7) 3 (21) 5 (12)
Recruitment source
Newspaper/magazine/
newsletter/email
advertisement
5 (17) 4 (29) 9 (21)
Research team
colleagues/personal
contacts
3 (10) 1 (7) 4 (9)
Advertisement seen by
participant’s friend/
colleague
6 (21) 5 (36) 11 (26)
Local radio 3 (10) 1 (7) 4 (9)
Online gout forum/website 3 (10) 2 (14) 5 (12)
Continued
Table 1 Continued
Men
(%)
(n=29)
Women
(%)
(n=14)
Total
(%)
(n=43)
Patient group 4 (14) – 4 (9)
Health professional 2 (7) 1 (7) 3 (7)
Internet search 1 (3) – 1 (2)
More than one source
(newspaper and radio)
1 (3) – 1 (2)
Unknown 1 (3) – 1 (2)
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you drink and eat lots of red meat and you’re overweight
and things like that, and you’re not. ( Judith, 61yrs)
Actions on receiving the diagnosis
Being diagnosed with gout was an immediate prompt
for further action by some patients. For example, they
spent time searching the internet for information about
the condition, joined internet forums or discussion
groups for people with gout, or asked their GP for refer-
ral to a specialist.
One key unanticipated finding that has not previously
been reported in the literature was that, after doing
research on the internet following diagnosis, two
patients had bought equipment to monitor their own
SUA levels.
I’ve got one of those little kits that you use. So I wanted
to make sure that […] wanted to understand my own
disease and manage my own disease, so I’ve been doing
that ever since. […] So, the first thing I did was, I cali-
brated my monitor with the blood test. […] that seemed
like an accurate representation of what the bloods were
telling me. […] And I’ve actually, at some points, titrated
my own dose of Allopurinol. (Adam, 41yrs)
Another common pattern was that patients began to
change their diets in response to information they read
on the internet, regardless of whether or not their GP
had recommended such changes.
DISCUSSION
This paper is the first to look specifically and in-depth at
patients’ pathways to initial consultation and experiences
of gout diagnosis. Several issues were raised by patients
that may have led to delays in their diagnoses. Owing to
its qualitative nature, the study also resulted in unantici-
pated findings31 around self-monitoring. It is not appro-
priate to draw inferences about the prevalence of
experiences from these qualitative data.38 However,
these do provide an insight into the nature and range of
issues that patients may experience in the diagnosis of
gout. This has implications for clinical practice in terms
of understanding and addressing delays in the diagnostic
interval, and improving patient experiences of gout
diagnosis.
Understanding delays in diagnosis
Consistent with other descriptions of processes leading
to diagnosis,34 35 patients analysed their symptoms to try
and identify the cause and to determine what action to
take. Evidence about patient decisions of how and when
to seek medical advice—particularly the fact that some
patients waited months or even years before consulting
—contributes to the understanding of why gout is some-
times diagnosed late in its clinical course.9 10 Links
between the reluctance to seek medical attention and
patients’ embarrassment of admitting to the pain of
gout have previously been reported,26 but the data here
suggest that other factors such as financial pressures,
first attacks occurring during trips outside the UK, self-
diagnosis and/or self-medication may also play a part.
Additional factors that may have caused delays (during
the diagnostic interval) for the patients in this study
included misdiagnosis, attacks in joints other than the
first MTP joint, female gender, and consultations taking
place after the period when symptoms were at their
peak intensity (when visible classical features of an
attack may have been less evident). These findings are
useful in identifying the range of factors that may con-
tribute to delayed diagnosis, and perhaps require
further exploration. In particular, it would be useful to
explore experiences of diagnosis with patients from a
wider range of ethnic backgrounds in order to ascertain
whether there are cultural factors contributing to
delayed diagnosis in some cases.
Implications for self-management
One unanticipated finding from the study is that diagno-
sis prompted several patients to proactively attempt to
take control of managing their condition by purchasing
equipment to self-monitor SUA levels. Given that this
finding has not been widely reported before, clinicians
should be aware that patients may be monitoring their
own SUA levels and may wish to discuss these. In add-
ition, this finding may be relevant for future studies
looking into the acceptability of self-monitoring or
self-titration.
Targeting information provision at diagnosis to improve
patients’ understanding and confidence
From the findings reported in this study, several key
areas can be identified where a more targeted approach
to information provision at diagnosis would improve
patients’ experiences. These are relevant both for infor-
mation provision in the consultation, and for decisions
about the information that is included in gout patient
information leaflets, websites or other materials.
The first issue is around the measurement of SUA
levels. Despite the fact that the results of SUA tests
cannot confirm or exclude a diagnosis of gout,5 6 find-
ings from this study suggest that the limitations in using
SUA levels for diagnostic purposes are not always (effect-
ively) communicated to patients. Understanding gout
has previously been stated as important for patient
adherence and self-management;11 39 40 so improving
patient understanding of this aspect of gout would be
beneficial.
The second key point is that male and female patients
may be resistant to being labelled with a diagnosis of
gout. Negative views about gout can impact on disease
management and adherence to urate-lowering therapy
(ULT).41–43 Emphasising that gout is a form of arthritis
may give patients greater confidence in accepting the
diagnosis and communicating it to others. In addition,
reassurance could be offered to female patients that,
although less common, it is not unusual for women to
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have gout. Research with patients from a wider range of
ethnic groups may also provide insights into providing
information to reflect any cultural differences in the
understanding or the experiences of gout.
The third issue centres around raising awareness of
gout as a chronic condition that requires long-term man-
agement.12 39 Patients leaving the consultation thinking
of gout as an intermittent, acute condition, clearly has
implications for their subsequent behaviour and percep-
tions of the need for ULT. If patients are not aware that
long-term management is important, they may be less
likely to return if they experience subsequent attacks,
relying instead on self-medication.
The fourth key finding is that getting an optimal
balance of information provision around lifestyle
factors12 may be difficult. Too great an emphasis, as per-
ceived by patients, was seen as judgemental, and rein-
forced misconceptions about the most common causes
of gout and concerns about the condition being per-
ceived as self-inflicted. On the other hand, perceiving
that they were not given enough information could leave
patients feeling ‘fobbed off’ and/or making drastic or
unhealthy changes to their diets. The other challenge is
for clinicians to balance information about non-
pharmacological approaches (which may initially be
prioritised by patients), and emphasis on more effective
(but potentially less acceptable to some patients)
pharmacological approaches.11 12 In addition, some
patients seemed prepared to accept information they
found on the internet despite the fact that this con-
flicted with advice from their GP. Previous research has
also found that some patients value online resources
more than doctors as information sources.44 Future
research could usefully explore these issues further in
the context of gout diagnosis.
Focusing on these key areas (reasons for measuring
SUA levels, gout as a form of arthritis, the chronic
nature of gout, and the links between gout and lifestyle
factors) in the consultation would increase confidence
in the diagnosis and treatment, and help to address mis-
conceptions about the causes of gout and the character-
istics of people who are diagnosed with it.
Strengths and limitations
This paper is the first to focus specifically on patients’
experiences of gout diagnosis, including their decisions
about how and when to first seek medical advice. The
sample of people from different social backgrounds and
age groups allowed for in-depth exploration and insight
into previously hidden experiences of patients with gout,
including those who fit the ‘typical’ gout profile and
those who do not. The study included patients from two
ethnic groups, but it would be useful to explore experi-
ences of diagnosis with patients from a wider range of
ethnic backgrounds in order to ascertain whether there
are cultural factors impacting on experiences of diagno-
sis in some cases. In addition, while accounts of patients’
experience are of high importance in achieving patient-
centred provision of healthcare, patients’ accounts and
understandings of what health professionals did and said
are, of course, their own perceptions. Retrospective
accounts of experiences may also change with time, or
reflect issues or ideas that are no longer prevalent in
current practice.
CONCLUSION
This study is the first to report data specifically about
patients’ pathways to initial consultation and subsequent
experiences of gout diagnosis. These data provide
insight into the nature and range of issues that patients
may experience in the diagnosis of gout. Such evidence
has implications for clinical practice in terms of under-
standing and addressing delays in diagnosis, and adopt-
ing a more targeted approach to information provision
at diagnosis to improve patients’ experiences.
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